Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Squamous Cell Carcinoma Esophagus: Demographics and Evaluation of Prognostic Factors at a Tertiary Care Center in India

被引:0
作者
Mithi, Mohamed Taher [1 ]
Sharma, Mohit [1 ]
Puj, Ketul [1 ]
Hazarika, Prandweep [1 ]
Pandya, Shashank J. [1 ]
Gandhi, Jahnavi [2 ]
Parikh, Ankita [3 ]
Shukla, Shivang [1 ]
机构
[1] Gujarat Canc Res Inst, Dept Surg Oncol, Ahmadabad 380016, Gujarat, India
[2] Gujarat Canc Res Inst, Dept Pathol, Ahmadabad 380016, Gujarat, India
[3] Gujarat Canc Res Inst, Dept Radiotherapy, Ahmadabad 380016, Gujarat, India
关键词
Esophageal cancer; Neoadjuvant chemoradiation; Pathological complete response; Squamous cell carcinoma; Esophagectomy; PATHOLOGICAL COMPLETE RESPONSE; ADVANCED RESECTABLE CARCINOMA; WALL THICKNESS; SINGLE-CENTER; CHEMORADIOTHERAPY; SURVIVAL; CANCER; TRENDS;
D O I
10.1007/s13193-023-01828-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neoadjuvant chemoradiation followed by surgery has been the standard of care for locally advanced carcinoma esophagus. We present our experience and inference of various factors associated with the same treatment and the prognostic influence of the same. A retrospective analysis of a cohort of 132 squamous cell carcinoma esophagus patients post neoadjuvant chemoradiation operated with curative intent was carried out. The 2-year overall survival rate was 64.5%. A pathological complete response was achieved in 32.5% of patients and was the only factor that significantly determined overall survival (p = 0.048). Neoadjuvant chemoradiation before surgery for locally advanced squamous cell cancer of the esophagus remains the standard of care with a pathological complete response being a significant factor in predicting overall survival. More prospective randomized studies are necessary to analyze factors affecting and predicting a pathological complete response which would help organ preservation in patients with a complete response.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
[21]   Impact of Delaying Surgery After Chemoradiation on Outcomes for Locally Advanced Esophageal Squamous Cell Carcinoma [J].
Wong, Lye-Yeng ;
Liou, Douglas Z. Z. ;
Vitzthum, Lucas K. K. ;
Backhus, Leah M. M. ;
Lui, Natalie S. S. ;
Chang, Daniel ;
Shrager, Joseph B. B. ;
Berry, Mark F. F. .
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) :2212-2223
[22]   Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Followed by Surgery [J].
Sugimura, Keijiro ;
Miyata, Hiroshi ;
Shinno, Naoki ;
Ushigome, Hajime ;
Asukai, Kei ;
Yanagimoto, Yoshitomo ;
Hasegawa, Shinnichiro ;
Takahashi, Yusuke ;
Yamada, Daisaku ;
Yamamoto, Kazuyoshi ;
Nishimura, Junichi ;
Motoori, Masaaki ;
Wada, Hiroshi ;
Takahashi, Hidenori ;
Yasui, Masayoshi ;
Omori, Takeshi ;
Ohue, Masayuki ;
Yano, Masahiko .
ONCOLOGY, 2019, 97 (06) :348-355
[23]   NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY TRANSHITAL ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IMPACT OF PATHOLOGICAL COMPLETE RESPONSE [J].
Fillardi Alves, Iuri Pedreira ;
Tercioti Junior, Valdir ;
Coelho Neto, Joao de Souza ;
Possatto Ferrer, Jose Antonio ;
Campello Carvalheira, Jose Barreto ;
Pereira, Eduardo Baldon ;
Lopes, Luiz Roberto ;
Andreollo, Nelson Adami .
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2021, 34 (03)
[24]   Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy [J].
Chen, Pengcheng ;
Wang, Liang ;
Yang, Xun ;
Feng, Jifeng .
BIOMOLECULES AND BIOMEDICINE, 2024, 24 (01) :159-169
[25]   Problems in neoadjuvant chemoradiotherapy preceding surgery for advanced squamous cell carcinoma of the thoracic esophagus. [J].
Ishida K. ;
Koeda K. ;
Sato N. ;
Ikeda K. ;
Ohtsuka K. ;
Aoki K. ;
Kimura Y. ;
Iwaya T. ;
Uesugi N. ;
Nakamura R. .
The Japanese Journal of Thoracic and Cardiovascular Surgery, 1999, 47 (6) :262-266
[26]   Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy [J].
Okumura, Hiroshi ;
Uchikado, Yasuto ;
Matsumoto, Masataka ;
Owaki, Tetsuhiro ;
Kita, Yoshiaki ;
Omoto, Itaru ;
Sasaki, Ken ;
Sakurai, Toshihide ;
Setoyama, Tetsuro ;
Nabeki, Bunpei ;
Matsushita, Daisuke ;
Ishigami, Sumiya ;
Hiraki, Yoshiyuki ;
Nakajo, Masayuki ;
Natsugoe, Shoji .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) :329-334
[27]   Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study [J].
Lian, Hui-min ;
Wu, Jia-liang ;
Liufu, Wei-jian ;
Yu, Tian-tian ;
Niu, Shao-qing ;
Bao, Yong ;
Peng, Fang .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (03)
[28]   Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma [J].
Koichi Ogawa ;
Hitoshi Ishikawa ;
Katsuji Hisakura ;
Yuichi Hiroshima ;
Toshikazu Moriwaki ;
Takeshi Yamada ;
Yoshiyuki Yamamoto ;
Yoshimasa Akashi ;
Yohei Owada ;
Yusuke Ohara ;
Tsuyoshi Enomoto ;
Kinji Furuya ;
Manami Doi ;
Osamu Shimomura ;
Kazuhiro Takahashi ;
Shinji Hashimoto ;
Hideyuki Sakurai ;
Tatsuya Oda .
International Journal of Clinical Oncology, 2021, 26 :1856-1863
[29]   Neoadjuvant chemoradiotherapy followed by surgery is associated with better survival outcomes in patients with locally advanced esophageal squamous cell carcinoma [J].
Yoshida, Naoya ;
Baba, Hideo .
JOURNAL OF THORACIC DISEASE, 2018, 10 :S3067-S3068
[30]   Novel pathological staging for patients with locally advanced esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by surgery [J].
Junya Oguma ;
Koshiro Ishiyama ;
Daisuke Kurita ;
Kyohei Kanematsu ;
Yusuke Fujii ;
Kentaro Kubo ;
Shun Yamamoto ;
Yoshitaka Honma ;
Ken Kato ;
Hiroyuki Daiko .
Esophagus, 2022, 19 :214-223